Infantile myofibromatosis is a rare disorder in which one or more noncancerous tumors grow in the skin, bone, muscle and soft tissue, and only rarely in the internal organs. The tumors do not spread to distant sites, but they can grow large enough to press on or damage nearby structures, and a form that involves the internal organs can be life-threatening. Most cases begin in infancy or early childhood, although adult-onset cases are described. The solitary form is the most common and tends to affect males, while the multiple forms are more common in females. Most cases arise without any known cause and without a family history, but rare families carry variants in the PDGFRB or NOTCH3 genes. The disorder was first described as a distinct entity in 1954 by Arthur Purdy Stout, who called it congenital generalized fibromatosis, and the name infantile myofibromatosis was introduced in 1981. Its incidence is estimated at between 1 in 150,000 and 1 in 400,000 live births. Many tumors regress on their own, surgery is the main option for focal tumors, and chemotherapy is reserved for cases that involve the internal organs and cannot be treated surgically. This entry records what the sources state and is not medical advice.
Facts
Classification
Communicable or Non-communicable Transmission Route First Described Prevalence1 in 150,000 to 1 in 400,000 live births 2 Prevalence Band Causative Agent
Causative Agent (category) Connections
Discovered By
Source Infantile Myofibromatosis (NORD)
Treats
Source Infantile Myofibromatosis (NORD)
Sources
1. Infantile Myofibromatosis (NORD)
Disease Overview, bone
the growth of one or more noncancerous (benign) tumors affecting the skin, bone, muscle, soft tissue and rarely the internal organs (viscera)
Disease Overview, muscle
the growth of one or more noncancerous (benign) tumors affecting the skin, bone, muscle, soft tissue and rarely the internal organs (viscera)
Causes
variants in two genes have been identified as causing the disorder in some people
Causes, genetic and familial cases
Rare cases of myofibromatosis have been identified that run in families
Causes, inherited not infectious
Most cases of infantile myofibromatosis occur randomly, for no apparent reason.
Introduction
Infantile myofibromatosis was first described as a distinct entity in the medical literature in 1954 by Dr. A.P. Stout.
Affected populations
estimated to be between 1 in 150,000 to 400,000 live births
Discovered By: Arthur Purdy Stout, Introduction, first description
Infantile myofibromatosis was first described as a distinct entity in the medical literature in 1954 by Dr. A.P. Stout.
Treats: Chemotherapy, Standard Therapies, chemotherapy
Chemotherapy may be used to treat cases where there is involvement of the internal organs and surgery was unsuccessful
View the Source2. Infantile myofibromatosis (Wikipedia)
Lead, incidenceQuote, Lead, incidence
Infantile myofibromatosis (IMF) is a rare tumor found in 1 in 150,000 to 1 in 400,000 live births.
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.